Benoît You, Alexandra Leary, Mathieu Jamelot, Pauline Parent, Coriolan Lebreton, Laurence Gladieff, Jean-Sebastien Frenel, Magali Provansal, Marie Meurer, Thibault De La Motte Rouge, Veronique D'hondt, Lauriane Eberst, Cécile Vicier, Pascale Tomasini, Diego Tosi, Sara Calattini, Touria Hajri, Verane Schwiertz, Fabien Subtil, Pierre-Adrien Bolze. "IMMUNORARE 5 : A national platform of 5 academic phase II trials coordinated by Lyon University Hospital to assess the safety and the efficacy of the immunotherapy with domvanalimab + zimberelimab combination in patients with advanced rare cancers—The Gestational Trophoblastic Tumors Cohort.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps5636